Research comparison
Ipamorelin vs CJC-1295
Side-by-side comparison of research status, mechanisms, pharmacokinetics, and administration routes.
Research Status
Preclinical
Preclinical
Half-Life
~2 hours
6–8 days (due to DAC albumin binding)
Mol. Weight
711.86 Da
3647.28 Da
Admin Routes
subcutaneous
subcutaneous
Categories
Growth Hormone Axis
Growth Hormone Axis
Interaction
synergistic
This is the canonical GHRH + GHRP stack: CJC-1295 stimulates pituitary GHRH receptors while ipamorelin activates GHS-R1a, producing amplified GH pulses that are greater than either peptide alone.
well-documented
Mechanism
Pharmacokinetics
Research Findings
Safety
Related comparisons